{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:52:17Z","timestamp":1785325937884,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.transci.2011.01.003","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T09:25:53Z","timestamp":1298366753000},"page":"119-122","source":"Crossref","is-referenced-by-count":6,"title":["Trend of indications for therapeutic plasma exchange at an Iranian university hospital"],"prefix":"10.1016","volume":"44","author":[{"given":"Shahrzad","family":"Shahidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Memarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manijeh","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsoon Emami","family":"Naini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2011.01.003_b0005","series-title":"A practical guide to therapeutic plasma exchange","author":"Kaplan","year":"1999"},{"key":"10.1016\/j.transci.2011.01.003_b0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1744-9987.1997.tb00151.x","article-title":"Spin doctors: new innovations for centrifugal apheresis","volume":"1","author":"Kambic","year":"1997","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0955-3886(99)00042-9","article-title":"The Canadian Apheresis Group and therapeutic plasma exchange","volume":"20","author":"Rock","year":"1999","journal-title":"Transfus Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jca.2920070202","article-title":"Therapeutic apheresis in Canada. The Canadian apheresis study group","volume":"7","author":"Rock","year":"1992","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0955-3886(95)00039-9","article-title":"International forum: France. The national survey of plasma exchange and therapeutic cytapheresis in France","volume":"16","author":"Korach","year":"1995","journal-title":"Transfus Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-0502(01)00090-8","article-title":"14years of therapeutic plasma exchange in France","volume":"25","author":"Korach","year":"2001","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1526-0968.2001.00336.x","article-title":"Apheresis technologies and clinical applications: the 2000 International Apheresis Registry","volume":"5","author":"Malchesky","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1525-1594.1987.tb02653.x","article-title":"The International Apheresis Registry: results of 1983 second pilot","volume":"11","author":"Malchesky","year":"1987","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2011.01.003_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<1::AID-JCA1>3.0.CO;2-R","article-title":"Introduction to the third special issue: clinical applications of therapeutic apheresis","volume":"15","author":"McLeod","year":"2000","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1526-0968.2003.00126.x","article-title":"Apheresis technologies and clinical applications: the 2002 international apheresis registry","volume":"8","author":"Malchesky","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2011.01.003_b0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0955-3886(00)00132-6","article-title":"Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group","volume":"24","author":"Norda","year":"2001","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0060","unstructured":"van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barre syndrome. Dutch Guillain\u2013Barre Study Group. N Engl J Med 1992;326:1123\u201329."},{"key":"10.1016\/j.transci.2011.01.003_b0065","unstructured":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barre Syndrome Trial Group. Lancet 1997;349:225\u201330."},{"key":"10.1016\/j.transci.2011.01.003_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1526-0968.2002.00401.x","article-title":"Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies","volume":"6","author":"Kincaid","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0075","doi-asserted-by":"crossref","unstructured":"The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group. Lancet 1991;337:441\u201346.","DOI":"10.1016\/0140-6736(91)93389-Q"},{"key":"10.1016\/j.transci.2011.01.003_b0080","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.35.3.312","article-title":"Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs","volume":"35","author":"Khatri","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2011.01.003_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jca.2920100402","article-title":"Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis","volume":"10","author":"Vamvakas","year":"1995","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-0502(03)00120-4","article-title":"Plasma exchange in France: epidemiology 2001","volume":"29","author":"Korach","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-131-6-199909210-00011","article-title":"Therapeutic plasma exchange: an update from the Canadian Apheresis Group","volume":"131","author":"Clark","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2011.01.003_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.transci.2005.03.007","article-title":"Therapeutic apheresis in the Philippines","volume":"33","author":"Narciso","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jca.2920060109","article-title":"Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG)","volume":"6","author":"Clark","year":"1991","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2011.01.003_b0110","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/art.1780371212","article-title":"Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide","volume":"37","author":"Euler","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2011.01.003_b0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1191\/0961203305lu2174rr","article-title":"Indications for plasma exchange in systemic lupus erythematosus in 2005","volume":"14","author":"Pagnoux","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2011.01.003_b0120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2011.01.003_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1473-0502(02)00095-2","article-title":"Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid","volume":"28","author":"Mazzi","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2011.01.003_b0130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mjd.2000.109297","article-title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","volume":"43","author":"Turner","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.transci.2011.01.003_b0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1526-0968.2003.00111.x","article-title":"Current status of therapeutic plasma exchange in Korea","volume":"8","author":"Song","year":"2004","journal-title":"Ther Apher Dial"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021100019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021100019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T18:58:03Z","timestamp":1560020283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305021100019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S147305021100019X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2011.01.003","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}